Incidence and risk factors for pacemaker implantation in light‐chain and transthyretin cardiac amyloidosis
Aldostefano Porcari(Azienda Sanitaria Universitaria Integrata di Trieste), Marco Merlo(Universidade da Coruña), Claudio Rapezzi(University of Ferrara), Giulia Barbati(University of Trieste), Beatrice Musumeci(Sapienza University of Rome), Camillo Autore(Sapienza University of Rome), Gianfranco Sinagra(Società Italiana di Cardiologia), Laura De Michieli(University of Padua), Gianluca Di Bella(University of Messina), Eugenio Sessarego(Ospedale Policlinico San Martino), Pier Filippo Vianello(Ospedale Policlinico San Martino), Guerino Giuseppe Varrà(University of Trieste), Federico Perfetto(Azienda Ospedaliero-Universitaria Careggi), Mattia Zampieri(Azienda Ospedaliero-Universitaria Careggi), Giulio Sinigiani(University of Padua), Giacomo Tini(Sapienza University of Rome), Domitilla Russo(Ospedale di Santo Spirito), Marco Canepa(Ospedale Policlinico San Martino), Alessia Argirò(University of Florence), Francesco Cappelli(National Institute of Optics), Carlo Fumagalli(Azienda Ospedaliero-Universitaria Careggi), Maria Cristina Morelli(Azienda Ospedaliero-Universitaria Careggi), Maddalena Rossi(University of Trieste), Alberto Cipriani(Azienda Ospedale - Università Padova)
Cited by 69
Related Papers
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Truncations of Titin Causing Dilated Cardiomyopathy
|New England Journal of Medicine|2012|1.5k
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2021|1.1k
Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death
|Circulation|2015|607
Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria
|International Journal of Cardiology|2020|557